BioLoomics
PrivateLast Round
Seed
Sep 19, 2023
Total Funding Raised
$9.3M
Momentum Score
50 /100
Company Overview
BioLoomics is a biotechnology company that develops antibody-drug conjugates (ADCs) for cancer therapies using directed evolution, synthetic biology, and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioLoomics Comps
Public and private peers based on sector, stage, and business model.
BioLoomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 19, 2023 | ||||
| Pre Seed | May 30, 2019 |
BioLoomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boom Capital Ventures | Seed |
| Horizons Ventures | Seed |
| TechU Ventures | Seed |
| Innovation Endeavors | Seed |
| BoxOne Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors grew 684% MoM to 1.3K.
BioLoomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioLoomics's valuation, stock price, and market status.
